Itaconix (AIM:ITX) raised its full-year revenue guidance after reporting record first-half sales, with the AIM-listed plant-based specialty polymers maker now expecting FY2026 revenue of no less than $14.8 million.
That figure sits ahead of prior analyst forecasts of $13.3 million, with the board also maintaining its expectation of a small positive EBITDA for the year, against analyst forecasts of $0.3 million.
Unaudited revenue for the six months to 30 June reached $8.3 million, up 72% from $4.8 million in the first half of 2025 and up 46% from $5.7 million in the second half.
Gross margin is expected to hold at 36%, in line with full-year 2025, reflecting tighter management of raw materials and supply chains.
Growth spanned all major product segments, led by Performance Ingredients for the dish detergent market, where strong reorder volumes combined with new unit-dose customers in EMEA and North America.
SPARX Formulated Solutions also grew, driven by increased use of SPARX formulations in North American unit-dose dish and laundry detergents.
The company is developing longer-term opportunities through its BIO*Asterix speciality monomers for paints and its new BioVail plant nutrition ingredient for crop production.
"We are pleased with progress across the business at this stage of the financial year", though re-order rates are yet to be firmly established, the board said.
Interim results are expected on or about 8 September.
